Pathogen or Plant Disease Detection and Monitoring Market: Focus on Product, Application, and Country Analysis - Analysis and Forecast, 2026-2031

The global pathogen or plant disease detection and monitoring market is projected to reach $1,158.9 million by 2031 from $637.8 million in 2025, growing at a CAGR of 10.27% during the forecast period 2026-2031. Growth is supported by the rising threat of fungicide resistance in crop pathogens, frequent outbreaks of emerging plant diseases, increasing demand for rapid field diagnostics, expansion of digital agriculture, and the need for integrated surveillance and decision-support systems.

The market covers products and services used to detect, identify, confirm, monitor, and report plant pathogens and disease risks across agricultural production systems. It includes diagnostic kits, laboratory services, digital solutions, remote sensing services, IoT sensor technology and data analysis services, and associated workflows used across open-field and controlled-environment agriculture. The scope covers fungi, oomycetes, bacteria, viruses, viroids, phytoplasmas, and other relevant plant-health targets. Solutions include rapid field diagnostics, PCR and molecular testing, serological testing, laboratory confirmation, remote sensing, connected monitoring, and digital disease-risk assessment.

Market Introduction

Plant disease diagnostics are moving from centralized, laboratory-led workflows toward decentralized and integrated plant-health systems. Conventional testing remains important for confirmation, certification, seed-health testing, outbreak investigations, and regulatory decisions, while rapid field diagnostics reduce the time between sampling and intervention. Portable PCR, LAMP, RPA, CRISPR-based diagnostics, lateral-flow immunoassays, biosensors, and microfluidic platforms are supporting commercialization of point-of-care testing.

Digital integration is becoming a defining market trend. Modern solutions combine field diagnostics, laboratory confirmation, remote sensing, IoT devices, weather information, farm-management software, and AI-supported decision support. These systems can associate samples with GPS coordinates, operator identity, collection time, laboratory results, disease-risk scores, and phytosanitary records, creating traceable workflows and recurring revenue opportunities through software subscriptions, analytics, alerts, and technical services.

Industrial Impact

The pathogen and plant disease detection ecosystem spans reagent and antibody suppliers, test-kit manufacturers, portable instrument developers, laboratory networks, agricultural service providers, digital agriculture platforms, distributors, research institutions, seed companies, growers, and plant-protection authorities. Manufacturers scale reagents, test strips, cartridges, kits, portable instruments, sensors, spore traps, and consumables, while digital providers deploy cloud platforms, analytical engines, mobile applications, data pipelines, and connected monitoring equipment.

Products reach end users through direct sales, specialist distributors, laboratories, agronomic service providers, government programs, and digital subscriptions. The value chain extends from sample collection and field testing to laboratory confirmation, disease-risk scoring, surveillance reports, early warnings, agronomic recommendations, and regulatory notifications. These outputs support treatment, containment, quarantine, crop removal, certification, and continued monitoring decisions.

Market Segmentation:

Segmentation 1: By Application

• Open Field
• Controlled Environment

Open Field to Lead the Pathogen or Plant Disease Detection and Monitoring Market (by Application)

Open-field agriculture is expected to remain the dominant application, increasing from $542.1 million in 2025 to $977.6 million by 2031 at a CAGR of 10.33%. Most cereals, oilseeds, pulses, cotton, potatoes, fruits, and plantation crops are cultivated across extensive outdoor areas, creating recurring demand for crop scouting, rapid field tests, laboratory confirmation, satellite monitoring, weather stations, and disease-risk models. Open fields are also more exposed to rainfall, wind, temperature fluctuations, humidity, contaminated soil, insect vectors, and movement of infected plant material, making continuous surveillance and early warning commercially important.

Segmentation 2: By End User

• Agronomists/Crop Consultants/Field Testing Service Providers
• Farmers, Growers, and Agricultural Professionals
• Researchers, Scientists, Universities, and Research Institutes
• Others

Agronomists/Crop Consultants/Field Testing Service Providers to Lead the Pathogen or Plant Disease Detection and Monitoring Market (by End User)

Agronomists, crop consultants, and field testing service providers are expected to remain the leading end-user group, increasing from $242.4 million in 2025 to $462.3 million by 2031 at a CAGR of 11.36%. These users act as intermediaries between field observations, diagnostic testing, laboratory interpretation, and crop-management decisions. Service providers can distribute advanced technologies across multiple farms without requiring every grower to purchase dedicated equipment, while recurring testing relationships and broader assay menus support continued demand.

Segmentation 3: By Product

• Diagnostic Kits
• Laboratory Services
• Digital Solutions

Laboratory Services to Lead the Pathogen or Plant Disease Detection and Monitoring Market (by Product)

Laboratory services are expected to remain the largest product category, increasing from $272.7 million in 2025 to $486.1 million by 2031 at a CAGR of 10.11%. Laboratories remain essential for confirmatory diagnosis, seed-health testing, phytosanitary certification, complex sample analysis, outbreak investigations, and tests requiring higher analytical sensitivity or specificity. Laboratory networks also increasingly integrate molecular diagnostics, sequencing, digital reporting, and specialist interpretation.

Segmentation 4: By Region

• North America: U.S., Canada, and Mexico
• Europe: U.K., Italy, France, Netherlands, Germany, Switzerland, Belgium, Spain, Bulgaria, Ukraine, and Rest-of-Europe
• Asia-Pacific: China, Japan, Australia, New Zealand, South Korea, India, and Rest-of-Asia-Pacific
• South America: Brazil, Argentina, and Rest-of-South America
• Middle East and Africa: South Africa, Turkey, Israel, and Rest-of-MEA

Asia-Pacific to Lead the Pathogen or Plant Disease Detection and Monitoring Market (by Region)

Asia-Pacific represented 32.8% of the global market in 2025 and is expected to remain the largest regional market through the forecast period. The region combines large cultivated areas, diverse crop systems, expanding agricultural digitalization, growing diagnostic infrastructure, and increasing need for disease surveillance. China, India, Japan, Australia, South Korea, and other Asian markets are strengthening laboratory, field-testing, and digital surveillance capabilities.

North America accounted for 27.1% of the 2025 market, supported by mature diagnostic laboratories, established plant-health networks, commercial agriculture, and adoption of molecular and digital diagnostics. Europe represented 24.9%, with demand supported by phytosanitary requirements, accredited laboratories, seed-health testing, and digital plant-health systems. South America accounted for 8.7%, supported by large commercial agriculture and disease surveillance requirements, while the Middle East and Africa accounted for 6.5% and provide opportunities through export agriculture, greenhouse production, biosecurity, and development-supported surveillance.

Demand - Drivers, Challenges, and Opportunities

Market Drivers

Rising Threat of Fungicide Resistance in Crop Pathogens

Fungicide resistance is increasing the importance of accurate pathogen identification and disease surveillance because treatment decisions increasingly depend on understanding the pathogen and its resistance characteristics. Repeated use of the same fungicide modes of action can select resistant pathogen populations, reducing treatment effectiveness and increasing crop-management costs. This strengthens demand for diagnostics that can support early identification, resistance monitoring, laboratory confirmation, and targeted crop-protection decisions.

Frequent Outbreaks of Emerging Plant Diseases

Emerging, re-emerging, and transboundary plant diseases are creating sustained demand for rapid field diagnostics, molecular confirmation, surveillance, and traceability systems. Climate change can alter temperature, rainfall, humidity, and seasonal patterns, while international trade in seeds, seedlings, nursery stock, and fresh produce creates additional opportunities for pathogen introduction. These conditions increase the commercial need for rapid diagnostics supporting surveillance, border inspection, quarantine, outbreak investigation, and traceability.

Market Challenges

Diagnostic Accuracy, Sample Integrity, and Data Security

Reliable plant-pathogen diagnosis depends on analytical performance as well as sample integrity and traceability throughout the testing workflow. Sample degradation, cross-contamination, matrix interference, cross-reactivity, operator variability, inadequate chain of custody, and environmental conditions can affect results. False-negative results can allow infected planting material to enter production or trade, while false-positive results can trigger unnecessary crop destruction, quarantine, export rejection, or treatment. As diagnostic workflows become decentralized and digitally connected, secure result storage, authentication, timestamping, geolocation, and traceable reporting are also increasingly important.

Rapid Adoption of Genetically Modified and Gene-Edited Crops

The growing commercialization of genetically modified and gene-edited crops is increasing diagnostic complexity rather than directly increasing disease incidence. Modified cultivars may show altered symptom development, disease progression, pathogen interactions, or physiological responses. Laboratories therefore need assays that accurately detect pathogens across conventional, genetically modified, and gene-edited cultivars while maintaining separation between pathogen diagnostics and biotechnology-event testing. The principal commercial implication is greater validation and assay-design requirements.

Market Opportunities

Innovations in Point-of-Care Diagnostics

Point-of-care diagnostics are one of the most attractive opportunities because they move testing to the location where disease-management decisions are made. Portable PCR, LAMP, RPA, CRISPR-based diagnostics, lateral-flow immunoassays, biosensors, and microfluidic platforms can reduce laboratory turnaround times and address limited laboratory access in remote agricultural regions. Commercial evolution is increasingly centered on sample-to-answer workflows incorporating simplified sample preparation, ambient-stable reagents, disposable cartridges, smartphone interpretation, cloud connectivity, and AI-supported decision support.

Rapid Adoption of Integrated Plant Health Solutions

Plant disease diagnostics are evolving from standalone testing products into integrated plant-health solutions combining field diagnostics, laboratory confirmation, remote sensing, IoT devices, weather information, farm-management software, and digital decision support. These platforms create opportunities for SaaS subscriptions, API licensing, disease alerts, cloud analytics, hardware maintenance, and data services. Suppliers capable of connecting diagnostics with digital agronomy, certification systems, export documentation, and precision crop-protection workflows can strengthen customer retention and recurring revenue.

How Can This Report Add Value to an Organization?

The report supports diagnostic manufacturers, agricultural laboratories, seed companies, agrochemical companies, precision-agriculture providers, growers, agronomists, phytosanitary authorities, investors, and technology developers by quantifying demand across application, end user, product, region, and country markets. Diagnostic manufacturers can assess opportunities in rapid tests, PCR, serology, and integrated molecular workflows. Laboratory providers can evaluate testing demand and regional expansion opportunities, while digital agriculture companies can identify growth opportunities in remote sensing, IoT, AI, disease-risk models, and connected plant-health platforms.

The report also provides competitive benchmarking, company market shares, recent product developments, mergers and acquisitions, partnerships, start-up funding, rapid-diagnostics mapping, regulatory pathways, pricing analysis, patent trends, and country-level market context. These insights can support market-entry, product-development, partnership, investment, and regional-expansion decisions.

Product/Innovation Strategy: Product strategy should prioritize sample-to-answer workflows, portable molecular diagnostics, rapid field tests, multiplex pathogen panels, ambient-stable reagents, simplified sample preparation, and smartphone-assisted interpretation. Manufacturers should expand coverage of fungal and oomycete pathogens, where field detection remains constrained by sample preparation and commercial assay availability. Digital integration should connect test results with GPS, weather, remote sensing, farm records, laboratory systems, and disease-risk models. Validation across crop varieties, pathogen strains, matrices, and operating environments should remain a core product-development priority.

Growth/Marketing Strategy: Growth strategies should prioritize agronomists, crop consultants, field testing service providers, laboratories, seed companies, and high-value growers that can scale diagnostic adoption across multiple farms and production programs. Asia-Pacific offers substantial expansion potential because of its large agricultural base and digitalization trajectory, while North America and Europe provide mature markets for validated diagnostics, seed-health testing, and integrated plant-health services. Partnerships with laboratories, seed companies, agrochemical suppliers, precision-agriculture platforms, government programs, and plant-protection organizations can accelerate market access and technical credibility.

Competitive Strategy: Competitive strategy should combine diagnostic accuracy with breadth of pathogen coverage, field usability, validation evidence, distribution reach, and digital integration. Established companies can strengthen positions through broader assay libraries, laboratory networks, and recurring services, while emerging companies can differentiate through portable molecular platforms, biosensors, AI, computer vision, remote sensing, and integrated data ecosystems. Mergers, acquisitions, partnerships, and OEM or white-label relationships can expand technology portfolios and accelerate commercialization. Companies should also invest in secure chain-of-custody workflows and interoperable reporting to meet increasingly demanding regulatory and commercial requirements.

Methodology

Primary Data Sources

The primary sources involve industry experts from the pathogen or plant disease detection and monitoring market and various stakeholders in the ecosystem. Respondents, including CEOs, vice presidents, marketing directors, and technology and innovation directors, have been interviewed to gather and verify both qualitative and quantitative aspects of this research study.

The key data points taken from primary sources include:

• validation and triangulation of all the numbers and graphs
• validation of report segmentations and key qualitative findings
• understanding the competitive landscape
• validation of the numbers of various markets for the market type
• percentage split of individual markets for geographical analysis

Secondary Data Sources

This research study involves the extensive use of secondary sources, including company websites, annual reports, investor presentations, press releases, white papers, scientific publications, product datasheets, diagnostic protocols, and industry directories. It also utilizes databases such as Hoover’s, Bloomberg, Businessweek, and Factiva to collect relevant and reliable information for a comprehensive, technology-focused, market-oriented, and commercial analysis of the global pathogen or plant disease detection and monitoring market. In addition to these sources, the study has been supported by data and insights from agricultural ministries, plant protection organizations, phytosanitary authorities, international organizations, patent databases, standards and regulatory bodies, crop research institutes, diagnostic laboratories, agricultural technology associations, and other credible public-domain sources to assess disease prevalence, diagnostic adoption, technology development, competitive positioning, laboratory-testing activity, digital surveillance deployment, and regional commercialization patterns.

Secondary research has been done to obtain crucial information about the industry’s value chain, revenue models, the market’s monetary chain, the total pool of key players, and the current and potential use cases and applications.

The key data points taken from secondary research include:

• segmentations and percentage shares
• data for market value
• key industry trends of the top players in the market
• qualitative insights into various aspects of the market, key trends, and emerging areas of innovation
• quantitative data for mathematical and statistical calculations

Key Market Players and Competition Synopsis

Competition in the global pathogen or plant disease detection and monitoring market is shaped by dedicated agricultural diagnostic companies, rapid-test manufacturers, laboratory service providers, molecular diagnostic specialists, digital agriculture companies, and technology developers. Leading participants are differentiating through broader pathogen coverage, faster testing workflows, and stronger integration of field screening with laboratory confirmation. Competitive positioning is increasingly shaped by lateral-flow tests, ELISA, PCR, qPCR, LAMP, portable molecular platforms, biosensors, remote sensing, connected sensors, artificial intelligence, and validated laboratory services. Strategic partnerships among diagnostic manufacturers, agricultural laboratories, universities, technology developers, distributors, and national plant protection organizations are becoming central to market access and technical credibility.

Leading participants are also increasing investment in portable molecular diagnostics, digital test interpretation, AI, computer vision, remote sensing, connected sensors, and cloud-based analytics. Product validation, quality assurance, sample-handling guidance, and technical support are becoming important competitive factors as buyers evaluate reliability across crops, matrices, and operating environments. Established specialists retain advantages through extensive pathogen libraries, validated antibodies, laboratory expertise, and distributor networks, while emerging companies compete through cartridge-based systems, CRISPR, biosensors, and simplified field workflows.

List of key companies profiled in the market report:

• Abingdon Health plc
• Agdia, Inc.
• BIOREBA AG
• Creative Diagnostics
• LOEWE Biochemica GmbH
• Agricolus S.r.l.
• OptiGene Limited
• REGA Biotechnology Inc.
• SignalChem Lifesciences Corporation (SLC)
• Norgen Biotek Corp.
• Tiaris Biosciences
• NIPPON GENE CO., LTD.

This product will be delivered within 3-5 business days.